Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).

Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B, REBOOT-CNIC investigators

Open source

DOI: 10.1093/ehjcvp/pvab060
Published: 2022 May 5
Container: European heart journal. Cardiovascular pharmacotherapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvab060,
  title = {Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).},
  author = {Rossello X and Raposeiras-Roubin S and Latini R and Dominguez-Rodriguez A and Barrabés JA and Sánchez PL and Anguita M and Fernández-Vázquez F and Pascual-Figal D and De la Torre Hernandez JM and Ferraro S and Vetrano A and Pérez-Rivera JA and Prada-Delgado O and Escalera N and Staszewsky L and Pizarro G and Agüero J and Pocock S and Ottani F and Fuster V and Ibáñez B and REBOOT-CNIC investigators},
  year = {2022},
  journal = {European heart journal. Cardiovascular pharmacotherapy},
  doi = {10.1093/ehjcvp/pvab060},
  url = {https://doi.org/10.1093/ehjcvp/pvab060}
}

RIS

TY  - JOUR
TI  - Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
AU  - Rossello X
AU  - Raposeiras-Roubin S
AU  - Latini R
AU  - Dominguez-Rodriguez A
AU  - Barrabés JA
AU  - Sánchez PL
AU  - Anguita M
AU  - Fernández-Vázquez F
AU  - Pascual-Figal D
AU  - De la Torre Hernandez JM
AU  - Ferraro S
AU  - Vetrano A
AU  - Pérez-Rivera JA
AU  - Prada-Delgado O
AU  - Escalera N
AU  - Staszewsky L
AU  - Pizarro G
AU  - Agüero J
AU  - Pocock S
AU  - Ottani F
AU  - Fuster V
AU  - Ibáñez B
AU  - REBOOT-CNIC investigators
PY  - 2022
JO  - European heart journal. Cardiovascular pharmacotherapy
DO  - 10.1093/ehjcvp/pvab060
UR  - https://doi.org/10.1093/ehjcvp/pvab060
ER  -

APA

X, R., S, R., R, L., A, D., JA, B., PL, S., M, A., F, F., D, P., JM, D. L. T. H., S, F., A, V., JA, P., O, P., N, E., L, S., G, P., J, A., S, P., F, O., V, F., B, I., & investigators, R. (2022). Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).. European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvab060

Source records

pubmed · retrieved 2026-09-26T00:52:26.108Z